RHOA and systemic lupus erythematosus: Previous studies have reported that inhibition of RhoA/ROCK signaling significantly reduced anti-dsDNA antibody levels in lupus-prone NZB/NZW F1 mice, effectively alleviated renal damage and reducing mortality (21).